News | Breast Density | November 30, 2017

Numerous Studies Highlight Importance of Quantitative Breast Imaging Analysis at RSNA 2017

Volpara Solutions' breast imaging software tools provide quantitative metrics to maintain consistent quality and accuracy in breast screening

Numerous Studies Highlight Importance of Quantitative Breast Imaging Analysis at RSNA 2017

November 29, 2017 — The importance of quantitative analysis in breast imaging was the focus of numerous abstracts accepted for presentation at the 103rd Annual Radiological Society of North America (RSNA) meeting, Nov. 26-Dec. 1 in Chicago. Four abstracts highlighted the use of Volpara Solutions' quantitative analysis tools for breast imaging. The tools provide actionable quantitative metrics for clinicians, including volumetric density, personalized dose, potential high risk, and other factors designed to maintain accuracy and drive consistent quality in breast screening.

Two research groups used Volpara to examine screening performance across breast density categories. In the study, "The Relationship between Quantitative Breast Density, Age and Cancer Detection Rate in a Large UK Breast Screening Population," Louise Wilkinson and colleagues looked at the influence of age and density on the cancer detection rate (CDR) in the UK screening program. Researchers included 70,435 screening mammograms from 63,577 women with 557 breast cancers, for an overall CDR of 0.8 percent. Breast density was assessed and categorized by Volpara Density Grades (VDG). The cohort was divided into nine age groups to compare CDR in the lowest (VDG 1) and highest (VDG 4) density women, stratified by age.  Results demonstrated that in younger women, extreme density (Volpara VDG4) appears to correspond to higher CDR, while the opposite is true for older women. The results suggest that the relationship between cancer detection rate and density may vary with age and thus age should be taken into account when stratifying women into different screening strategies based on density.

Additionally, results from the UK TOMMY trial established that screening sensitivity appears to be significantly increased for women with intermediate density (4.5 to 15.5 percent Volpara density) compared to those with very high or very low density. In the study, "Using Quantitative Analysis to Understand How Performance of Digital Breast Tomosynthesis Varies with Breast Density," the addition of digital breast tomosynthesis (DBT) significantly increased the specificity of 2-D mammography for all breast density subgroups but only significantly increased sensitivity in patients with quantitative breast density in the middle ranges. The results suggest that DBT may not improve cancer detection in women with very low or very high breast density.

In "Radiation Dose from Tomosynthesis and Digital Mammography versus Quantitative Breast Density," VolparaDensity was used to measure personalized radiation dose across VDGs on 4,764 DBT exams and digital mammograms, obtained by the same acquisition system in the same breast compression. Results showed that the mean glandular dose (MGD) for the four breast density categories were higher with tomosynthesis than mammography. However, the results also show an inverse relationship between VDG and dose in the DBT exams, and that the relative dose increase is higher for fatty breasts and lower for dense breasts.  

Melissa Hill, Ph.D., of Volpara presented results about a new contrast-to-noise ratio (CNR) metric in "A Contrast-to-Noise Ratio for Clinical Mammographic Images." The novel approach for objectively measuring CNR on clinical images (as opposed to phantom) shows near-perfect correlation to EUREF's current method of measuring CNR from phantom images. As the first description of an objective CNR measure that can be made directly from mammographic images, this technique may enable real-time and patient-specific image quality evaluation.  

Volpara Solutions showcased its entire suite of quantitative breast imaging tools, including introducing near real-time positioning feedback, during RSNA.

For more information: www.volparasolutions.com

 

Related Content

Joseph J. Cappello Named Executive Director of Are You Dense Nonprofits
News | Breast Density | February 20, 2019
The boards of Are You Dense Inc. and Are You Dense Advocacy Inc., founded by the late Nancy M. Cappello, Ph.D.,...
Congress Directs FDA to Establish Federal Breast Density Inform Standard
News | Breast Density | February 19, 2019 | Jeff Zagoudis, Associate Editor
As part of a federal spending bill passed late Friday, Congress directed the U.S. Food and Drug Administration (FDA) to...
Amazon Comprehend Medical Brings Medical Language Processing to Healthcare
News | Artificial Intelligence | February 15, 2019
Amazon recently announced Amazon Comprehend Medical, a new HIPAA-eligible machine learning service that allows...
Densitas Enters Partnership Agreement With TeleMammography Specialists
News | Breast Density | February 14, 2019
Breast imaging analytics company Densitas Inc. announced a new collaboration partnership with TeleMammography...
Hologic Launches Unifi Analytics Business Intelligence Tool
Technology | Analytics Software | February 12, 2019
Hologic Inc. announced the U.S. launch of Unifi Analytics, a business intelligence tool that allows healthcare...
Mount Sinai's Digital 3-D Mammography Van Rolls Into New York City
News | Mammography | February 11, 2019
Mount Sinai Hospital recently launched the Mount Sinai Mobile Mammography Program (MMP), bringing essential breast...
breast density cancer awareness
News | Breast Density | February 08, 2019
Governor Michelle Lujan Grisham has signed breast density inform bill, ...
Fujifilm Launches Latest Synapse 3D Version at HIMSS 2019

The new Intravoxel Incoherent Motion (IVIM) MR application in Synapse 3D

Technology | Advanced Visualization | February 08, 2019
Fujifilm Medical Systems U.S.A. will debut the latest version of its Synapse 3D solution at the Healthcare Information...
Siemens Healthineers Syngo.Breast Care Adding AI-Based Decision Support
News | Clinical Decision Support | February 05, 2019
Siemens Healthineers showcased the new planned artificial intelligence (AI)-based features with its mammography reading...
Study Assesses Risk of MRI Exams for Patients With Tattoos
News | Magnetic Resonance Imaging (MRI) | February 01, 2019
A new European study concluded that magnetic resonance imaging (MRI) exams pose little risk for people with tattoos,...